Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3170
Selected: 0
NCT IDTitle
NCT04058964Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic Cancer
NCT05704634A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer.
NCT03830164Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer
NCT04553744Identification of Surgical Management of Lymph Node Basins and Surgical Practice Patterns Among Sarcoma Surgeons
NCT00790855Bendamustine in Acute Leukemia and MDS
NCT05053867A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
NCT06807606Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
NCT01248247BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
NCT04794816What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care
NCT03776487Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer
NCT06870916Supporting Informed Decision Making About Multi-cancer Early Detection Testing
NCT01176604Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma
NCT01952847Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
NCT00294632Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma
NCT01254890Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome
NCT00493688A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
NCT03069326A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis
NCT00054691ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin
NCT04029038Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma
NCT01010217Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
NCT05177796Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer
NCT00575718Smoking Cessation Intervention for Cancer Patients
NCT06967610Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
NCT03990597StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord
NCT03059940Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
NCT00254397Melanoma Vaccine With Peptides and Leuprolide
NCT03177460Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer
NCT06445959Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib
NCT00129740Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)
NCT06167291Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)
NCT02194374Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL)
NCT01439659Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer
NCT00528762Mexican and African American Family Focus Groups on Puberty
NCT00493350Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer
NCT00317720Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer
NCT04047797Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
NCT00500513Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials
NCT01117740Pleural Catheters Versus Thoracoscopic Pleurodesis
NCT02420613Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma
NCT02599649Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)
NCT00954226Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer
NCT05024968Sintilimab in Cancer of Unknown Primary
NCT03485950Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
NCT00354978Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients
NCT05017025Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer
NCT00422591Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
NCT06550050Clinical and Molecular Features of Oral Premalignancy and Oral Cancer
NCT00227656Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer
NCT03674229Patients Navigators in Facilitating Weight Management in Obese Participants
NCT00868595MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer